Abstract
Abstract Submission Information
Submission Deadline: September 30, 2025
Submission Deadline: September 30, 2025
How to Submit your abstract
You can submit your abstract on the FLORETINA ICOOR CONGRESS 2025 Abstract Submission Portal.
Submission deadline: September 30, 2025.
The notification of acceptance or rejection of your submitted abstract will be sent to you by e-mail by November 15, 2025.
Abstract submission
Your abstract must be submitted online.
To submit your abstract, you must have an account created on the platform.
The account will allow you to access all your created/submitted abstracts, learn about their status (accepted/rejected).
Opportunities for residents and Young Ophthalmologists
As part of our strong commitment to the next generation of eye care professionals, FLORetina-ICOOR offered 10 exclusive grants for young ophthalmologists under 35. To be considered for a grant, candidates were invited to submit an abstract by following the standard submission process, open to all participants.
We’re excited to announce that the Scientific Committee of the FLORetina-ICOOR 2025 Congress has selected the 10 most outstanding contributions from young ophthalmologists for this year’s FLORetina Grants!
Meet the Winners!
ROBOTIC SUBRETINAL TPA INJECTION STUDY
Ivo De Clerck¹, Emmanuel Vander Poorten², Mouloud Ourak², Maarten Schoovaerts², Martina Polidoro², Peter Stalmans¹
1. UZ Leuven, Leuven, Belgium; 2. KU Leuven, Leuven, Belgium
QUANTITATIVE ASSESSMENT OF PERIPHERAL CHOROIDAL VASCULATURE ON UWF ICGA IN POSTERIOR UVEITIS USING ADVANCED IMAGING PROCESSING TECHNIQUES
Ashish Markan¹, Vishali Gupta²
1. AIIMS, New Delhi, India; 2. PGIMER, Chandigarh, India
PERILESIONAL FAF PATTERNS ARE NOT STATIC: LONGITUDINAL SHIFTS IN GA AND THEIR CLINICAL SIGNIFICANCE
Alessio Antropoli, Francesco Vacirca, Ugo Introini, Francesco Bandello, Maurizio Battaglia Parodi, Maria Vittoria Cicinelli
IRCCS San Raffaele Scientific Institute, Milan, Italy
RETINAL VASCULITIS DOUBLES STROKE RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Yousef Fouad¹, Marina El Sayed², Edmund Tsui³
1. Ain Shams University, Cairo, Egypt; 2. University of California, Riverside, United States of America; 3. University of California, Los Angeles, United States of America
EXOGENOUS TESTOSTERONE USAGE INCREASES THE RISK OF CENTRAL SEROUS CHORIORETINOPATHY
Hong-Uyen Hua¹, Emilio Roig¹, Arnal Leo², Yeabsira Mesfin³, Karen M Wai², Ehsan Rahimy⁴, Chase A Ludwig²
1. Bascom Palmer Eye Institute, University of Miami, Miami, United States of America; 2. Byers Eye Institute, Stanford University School of Medicine, Palo Alto, United States of America; 3. University of California, San Francisco School of Medicine, San Francisco, United States of America; 4. Palo Alto Medical Foundation, Palo Alto, United States of America
LONGITUDINAL QUANTITATIVE EVALUATION OF RETINAL AND CHOROIDAL VASCULATURE IN DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY USING OCT, OCTA, AND SEMI-AUTOMATED MATLAB METHODS
Pinar Güran Begar¹, Sibel Demirel², Özge Yanik Odabas²
1. Tatvan State Hospital, Bitlis, Turkey; 2. Ankara University Faculty of Medicine, Ankara, Turkey
AN AI-BASED TRIAGE SYSTEM FOR MACULOSCHISIS IN HIGH MYOPIA: INTEGRATING OCT IMAGING AND PATIENT METADATA FOR OPTIMIZED REFERRAL DECISION SUPPORT
Anas Abu Said, Shihao Chen, Yanfeng Su
Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou, China
VITELLIFORM LESIONS ASSOCIATED WITH ANGIOID STREAKS: LONG-TERM FOLLOW-UP OF A RARELY DESCRIBED PHENOTYPE
Alessandro Feo¹, Elodie Bousquet³, Livia Faes⁴, Prithvi Ramtohul⁴, Riccardo Sacconi⁵, Federico Rissotto⁵, Giacomo Boscia⁶, Neda Abraham¹, Tal Eshkoly Lior¹, Shahin Faghihi¹, Marko M Popovic¹, Hiok Hong Chang¹, Chui Ming Gem Cheung⁷, Yousef Fouad⁸, Diogo Cabral⁹, Andrea Govetto¹⁰, Mario R Romano¹⁰, Giuseppe Querques⁵, SriniVas R Sadda⁶, K Bailey Freund⁴, David Sarraf¹
1. Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, University of California of Los Angeles, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America; 2. School of Medicine at UCLA, Los Angeles, California, USA; 3. Department of Ophthalmology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, France; 4. Vitreous Retina Macula Consultants of New York, New York, United States of America; 5. School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; 6. Department of Ophthalmology, Doheny Eye Institute, University of California Los Angeles, Los Angeles, California, United States of America; 7. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; 8. Ophthalmology Department, Ain Shams University Hospitals, Cairo, Egypt; 9. Department of Ophthalmology, Unidade Local de Saúde Almada Seixal, Almada, Portugal; NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal; 10. Department of Ophthalmology, Eye Unit Humanitas Gavazzeni-Castelli, Bergamo, Italy.
MULTIMODAL ANALYSIS OF CONFLUENT HYPO-AUTOFLUORESCENCE AND ITS EVOLUTION IN CENTRAL SEROUS CHORIORETINOPATHY
Vasileia Chatzistergiou, Boris Marguier, Alain Gaudric, Aude Couturier, Elodie Bousquet
Université Paris Cité, Ophthalmology Department, AP-HP, Hôpital Lariboisière, Paris, France
INCIDENCE AND OUTCOMES OF CYSTOID MACULAR EDEMA FOLLOWING SOLEKO CARLEVALE IOL IMPLANTATION
Nicolas Echeverria, Angel Lopez Vazquez, Julio Gonzalez Lopez, Diego Ruiz Casas, Ines Contreras Martin
Hospital Universitario Ramon y Cajal, Madrid, Spain
! NEW OPPORTUNITY !
Thanks to the unconditional support of
We‘re pleased to launch a new opportunity for additional awards!
Who‘s eligible?
- •Young Ophthalmologists who:
- -Submitted abstracts not selected in the first round
- -Submitted abstracts after May 31st
- -Plan to submit by July 31st
- •Residents who submit abstracts by July 31st
What does the grant include?
- •Complimentary registration and 3 nights of hospitality
- •Mentorship with leading experts
- •Hands-on training & wet lab access
- •Opportunity to present a clinical case in a webinar on FLORetina.com
SUBMIT YOUR ABSTRACT BY July 31st TO BE CONSIDERED!
Submit your abstract